GS XJG Pill - orange oval, 20mm
Generic Name: lapatinib
Pill with imprint GS XJG is Orange, Oval and has been identified as Tykerb 250 mg. It is supplied by GlaxoSmithKline.
Tykerb is used in the treatment of Breast Cancer, Metastatic; Breast Cancer and belongs to the drug classes EGFR inhibitors, HER2 inhibitors. There is positive evidence of human fetal risk during pregnancy. Tykerb 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GS XJG
Tykerb
- Generic Name
- lapatinib
- Imprint
- GS XJG
- Strength
- 250 mg
- Color
- Orange
- Size
- 20.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- EGFR inhibitors, HER2 inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- GlaxoSmithKline
- Inactive Ingredients
-
magnesium stearate,
microcrystalline cellulose,
povidone,
sodium starch glycolate type A potato,
FD&C Yellow No. 6,
hypromelloses,
polyethylene glycol,
polysorbate 80,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00173-0752 (Discontinued) | GlaxoSmithKline |
| 00078-0671 | Novartis Pharmaceuticals Corporation |
More about Tykerb (lapatinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: EGFR inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
